2025
SJR Q2
JCR Q2 · 3,9
67 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Pharmaceutical Sciences
- Yayıncı
- Elsevier B.V.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0022354915206017
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,711
- Quartile Q2
- H-Index 224
- Atıf/yayın 3,97
- Doküman (3y) 1.027
- Atıf (3y) 4.194
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,9
- 5Y JIF 4,1
- JCI 0,83
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Pharmaceutical Science Q2
Alanlar
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Chemistry, Medicinal | Chemistry, Multidisciplinary | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,711 | 3,9 | 4,1 | 0,83 | Q2 | 224 |
| 2024 | Q1 | Q2 | 0,737 | 3,8 | 3,7 | 0,88 | Q2 | 216 |
| 2023 | Q2 | Q2 | 0,705 | 3,7 | 3,5 | 0,87 | Q2 | 216 |
| 2022 | Q2 | Q2 | 0,659 | 3,8 | 3,7 | 0,88 | Q2 | 216 |
| 2021 | Q2 | Q2 | 0,625 | 3,8 | 4,1 | 0,89 | Q2 | 216 |
| 2020 | Q1 | Q2 | 0,776 | 3,5 | 4 | 0,89 | Q1 | 216 |
| 2019 | Q1 | Q2 | 0,755 | 3 | 3,2 | 0,88 | Q1 | 216 |
| 2018 | — | Q2 | — | 3,2 | 3,4 | 0,91 | Q1 | — |
| 2017 | Q1 | Q2 | 0,984 | 3,1 | 3 | 0,89 | Q2 | 216 |
| 2016 | Q1 | Q2 | 1,01 | 2,7 | 2,9 | — | — | 216 |
| 2015 | Q1 | Q2 | 0,968 | 2,6 | 3,1 | — | — | 216 |
| 2014 | Q1 | Q2 | 1 | 2,6 | 3,1 | — | — | 216 |
| 2013 | Q1 | Q2 | 1,267 | 3 | 3,4 | — | — | 216 |
| 2012 | Q1 | Q2 | 1,419 | 3,1 | 3,4 | — | — | 216 |
| 2011 | Q1 | Q2 | 1,413 | 3,1 | 3,3 | — | — | 216 |
| 2010 | Q1 | Q2 | 1,423 | 3 | 3,3 | — | — | 216 |
| 2009 | — | Q1 | — | 2,9 | 3,1 | — | — | — |
| 2008 | — | Q1 | — | 3 | 3,1 | — | — | — |
| 2007 | — | Q1 | — | 2,9 | 2,9 | — | — | — |
| 2006 | — | Q1 | — | 2,2 | — | — | — | — |
| 2005 | — | Q1 | — | 2,2 | — | — | — | — |
| 2004 | — | Q1 | — | 2,2 | — | — | — | — |
| 2003 | — | Q1 | — | 2,1 | — | — | — | — |
| 2002 | — | Q1 | — | 2 | — | — | — | — |
| 2001 | — | Q1 | — | 2,1 | — | — | — | — |
| 2000 | — | Q1 | — | 2,1 | — | — | — | — |
| 1999 | — | Q1 | — | 2,3 | — | — | — | — |
| 1998 | — | Q1 | — | 1,8 | — | — | — | — |
| 1997 | — | Q1 | — | 1,5 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 31/72 |
| 2025 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 105/250 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 113/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 27/72 |
| 2024 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 91/239 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 92/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 29/72 |
| 2023 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 86/231 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 90/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 27/60 |
| 2022 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 78/178 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 105/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 30/63 |
| 2021 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 83/179 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 125/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 31/62 |
| 2020 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q1 | 77/178 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 132/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 27/61 |
| 2019 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q1 | 76/177 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 110/271 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 25/61 |
| 2018 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q1 | 64/172 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 90/267 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 21/59 |
| 2017 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 69/171 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 93/261 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 26/60 |
| 2016 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 65/166 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 113/257 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 29/59 |
| 2015 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 59/163 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 97/255 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 26/59 |
| 2014 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 49/157 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 109/255 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 20/58 |
| 2013 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 43/148 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/256 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 18/59 |
| 2012 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 41/152 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 71/261 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 19/59 |
| 2011 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 41/154 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 75/261 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 14/54 |
| 2010 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 37/147 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 78/252 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 15/46 |
| 2009 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 35/140 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 80/237 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 12/41 |
| 2008 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 28/127 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 70/219 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 10/41 |
| 2007 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 25/128 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 62/205 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 13/35 |
| 2006 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 29/124 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 89/199 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 12/34 |
| 2005 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 23/125 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 74/193 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 11/36 |
| 2004 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 26/125 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 68/187 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 10/37 |
| 2003 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 27/123 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 68/185 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 13/35 |
| 2002 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 24/119 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 63/188 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 11/36 |
| 2001 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 20/118 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 52/186 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 8/35 |
| 2000 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 21/118 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 48/181 |
| 1999 | CHEMISTRY | SCIE | Q1 | — | 17/121 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 7/30 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 38/175 |
| 1998 | CHEMISTRY | SCIE | Q1 | — | 21/126 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 9/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 45/178 |
| 1997 | CHEMISTRY | SCIE | Q1 | — | 27/111 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 13/28 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 55/157 |